- Research & development
- Life Sciences
Construction begins on the Centre of Precision Medicine
The future-oriented project of the Medical University of Vienna to promote research in the field of personalised and digital medicine has moved into the construction phase. More than 6,000 m² of modern conditions for research into this future-oriented field of medicine are being created at the Medical University of Vienna Campus at Vienna General Hospital.
By the end of 2026, approximately 200 researchers at the Eric Kandel Institute - Centre for Precision Medicine will have the ideal infrastructure to develop preventative, diagnostic and therapeutic methods tailored to individual patients.
The costs amounting to about € 90 million will be covered by EU funds and donations. The institute's namesake and Nobel laureate Eric Kandel, Professor emeritus of Physiology and Psychiatry at Columbia University in New York. Stated: “The founding of this institute will ensure that the Medical University of Vienna will continue to hold a leading position in research and innovation worldwide in the future.”
The more than 6,000 m² of floor space in the new research building will provide room for various highly specialised units to explore the opportunities of personalised and digital medicine, the two most important trends in medical science in the 21st century. For example, around 500 m² each are earmarked for computer-based biomedicine projects, technology platforms and a biobank.
- Learn more about the research location Austria
Attractive research and innovation location27. February 2024
ABA’s INVEST in AUSTRIA business area coordinated the handling of 1,354 inquiries on the part of international companies in 2023 and ended up overseeing 496 ongoing business location and expansion projects.
Novartis invests about € 500 million in its Austrian facilities27. February 2024
The investment strengthens the Tyrolean Kundl/Schaftenau campus as a leading biotech location in Europe and helps accelerate the continuous supply of biopharmaceuticals from Austria. The Schaftenau plant is scheduled to be fully operational in the summer of 2024, whereas the Kundl facility will be operational in the autumn of 2025, creating 350 new high-skilled jobs on campus.